-
Ndị na-ahụ maka ọrịa cancer: Ọrịa cancer zuru ụwa ọnụ na ...
MINI Ntụleghachi The outpost megide ọrịa cancer: eluigwe na ala cancer naanị akara Chengchen Qian1, Xiaolong Zou2, Wei Li1,3, Yinshan Li4, Wenqiang Yu5 1Shanghai Epiprobe Biotechnology Co., Ltd, Shanghai 200233, China;2 Department of General Surgery, the First Mffiliated Hospital of...GỤKWUO -
Ihe nchọpụta mbụ nke Epiprobe Biotech mepụtara ...
Na Eprel 20, 2024, Ndị Ọkachamara Nkwenye na Nchọpụta na Ngwa Clinical nke Tumor DNA Methylation Markers (nke a na-akpọkarị "Consensus"), nke Kọmitii Ọkachamara nke Tumor Markers Professional Comm gbakọtara.GỤKWUO -
Epiprobe Biotech na-agbawa nsogbu nke cervical ...
Ọrịa kansa cervical bụ ọrịa kansa nke na-akpagbu ụmụ nwanyị ogologo oge, na-enwe ihe karịrị 500,000 ọrịa kansa cervical ọhụrụ n'ụwa niile kwa afọ yana ihe karịrị 300,000 na-anwụ kwa afọ.Ọnọdụ mgbochi na ọgwụgwọ ọrịa kansa cervical na China dị oke njọ, yana nhụta nke ce...GỤKWUO -
Ngwa nchọpụta DNA methylation maka endometrial ...
Ọrịa cancer endometrial bụ ajọ ọrịa gynecology juru ebe niile, na nchọpụta mmalite ya dị oke mkpa maka ọgwụgwọ nke ọma.Ngwa nchọpụta DNA methylation apụtala dị ka ngwa na-ekwe nkwa maka nchọpụta mmalite nke ọrịa cancer endometrial.Emebere ngwa ndị a iji chọpụta ụdị...GỤKWUO -
Akụkọ netwọkụ CCTV: Epiprobe Biotech 100,000 c...
Wepu kansa cervical, Yi spectrum na-arụ ọrụ.Netwọk CCTV na Machị 6 bipụtara vidiyo akụkọ banyere mmalite nke nnukwu ọrụ ọdịmma ọha iji gbochie ọrịa kansa cervical na Shandong Province "Na-ewepụ cervical ...GỤKWUO -
Ndị otu nyocha Mahadum Fudan na-ezube ọzọ…
Na Julaị 6, 2022, ndị otu nyocha nke Dr. Yu Wenqiang duziri na Institutelọ Ọrụ Nnyocha nke Mahadum Fudan jikọtara ya na Fudan University Shanghai Cancer Center, na mmekorita ya na ndị otu ahụ na ụlọ ọgwụ Xijing Medical University nke Airforce, chọpụtara nke atọ ...GỤKWUO -
Ụlọ ọrụ Epiprobe meriri aha "Specia...
N'oge na-adịbeghị anya, Shanghai Municipal Commission of Economy and Information Technology kwupụtara ndepụta nke ụlọ ọrụ dị nta na nke obere Shanghai bụ ọkachamara, nhazigharị, ihe dị iche iche na ọhụụ (nke abụọ) na 2022. Shanghai Epiprobe Biotechnology Co., Ltd. dabere na ọkachamara ya. ..GỤKWUO -
A na-amata ngwa nchọpụta ọrịa cancer urothelial ...
Na mbido Mee 2023, TAGMe DNA Methylation Kit (qPCR) maka Ọrịa Urothelial nke Shanghai Epiprobe Biotechnology Co., Ltd mepụtara n'onwe ya, nwetara “Nhazi Ngwaọrụ Breakthrough” sitere na US FDA.Mmemme Ngwaọrụ FDA Breakthrough US chọrọ iji hụ na ịkwalite…GỤKWUO -
TAGMe DNA Methylation Kits (qPCR) maka...
Ngwọta maka ọrịa cancer endometrial, na-ewepụ ọrịa cancer na ọkwa nke ọnya ọrịa.Ọrịa cancer endometrial bụ otu n'ime ọrịa kansa atọ kachasị njọ na-arịa ọrịa gynecology.Ọrịa cancer endometrial bụ otu n'ime ọrịa kansa na-adịghị mma na usoro ọmụmụ ụmụ nwanyị, ranki ...GỤKWUO -
Epiprobe's pan-cancer biomarker sochiri ...
The "Angel Project" na-enyere aka nkenke ọgwụ ibelata ịda ogbenye.Na February 19, 2023, Central Committee of the Chinese People's Political Consultative Conference (CPPCC) na Siemens jikọrọ aka kwalite Guardian Angel Project na Gansu Province, na-enye onyinye dị elu ...GỤKWUO -
Epiprobe agafeela nke ọma ISO13485 Q ...
Ngwaahịa a pụrụ ịdabere na ya ma kwụsie ike bụ usoro ndụ nke ụlọ ọrụ.Ebe ọ bụ na e hiwere ya ihe fọrọ nke nta ka ọ bụrụ afọ 5 gara aga, Epiprobe na-ebute ịdịmma mbụ, na-enye ndị ọrụ ngwaahịa nyocha ọrịa kansa dị elu na ntụkwasị obi.Na Mee 9, 2022, ka onye ọkachamara nyochachara ya.GỤKWUO -
Ahụike Baidu na Epiprobe na-akwado nkwado…
Ọkt. 30, 2022, Baidu Health Internet Hospital (nke a na-akpọ "Baidu Health") na Shanghai Epiprobe Biotechnology Co., Ltd. (nke akpọrọ "Epiprobe") ekwupụtala imekọ ihe ọnụ iji kwalite nyocha mbụ pan-cancer na ụlọ ọgwụ na izugbe. ọwa ahụike duri...GỤKWUO
